• Explore /
  • Poster
  • / Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) cancer: Long-term follow up from KEYNOTE-059.

Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) cancer: Long-term follow up from KEYNOTE-059.

Abstract Poster

Authors

null

Zev A. Wainberg

David Geffen School of Medicine at UCLA, Los Angeles, CA

Zev A. Wainberg , Harry H. Yoon , Daniel V.T. Catenacci , Shadia Ibrahim Jalal , Kei Muro , Marcelo Garrido , Talia Golan , Toshihiko Doi , Ravit Geva , Geoffrey Yuyat Ku , Jonathan Scott Bleeker , Yung-Jue Bang , Hiroki Hara , Hyun Cheol Chung , Jiang Dian Wang , Andrea Hazzard , Sukrut Shah , Charles S. Fuchs

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT02335411

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4009)

DOI

10.1200/JCO.2019.37.15_suppl.4009

Abstract #

4009

Poster Bd #

114

Abstract Disclosures

Similar Posters

First Author: Yung-Jue Bang

First Author: Sun Young Rha

First Author: Zev A. Wainberg

First Author: Zev A. Wainberg